anti-inflammatoty and immuno-therapy living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 all comers	COVID-19 mild to moderate

	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
anti GM-CSF
mavrilimumab	MASH-COVID ...
clarithromycine			Rashad ...
colchicine	COLCOVID Salehzadeh GRECCO-19 RECOVERY ... Horby		COL-COVID ...
Colchicine plus rosuvastatin	Gaitan-Duarte ...
non-steroidal anti-inflammatory drugs
Indomethacin			Ravichandran
stem cells	Lanzoni Carmenate ...
corticosteroids
dexamethasone	RECOVERY dexamethasone
methylprednisolone	Tang X Metcovid Ranjbar
Immunostimulants drugs
convalescent plasma treatment	ConCOVID ... ConPlas-19 COP-COVID-19 CONTAIN COVID-19 PC/COVID-19 NCT04397757 CONCOR-1 NCT04442191 DAWN-Plasma NCT04385199 COPLA-II trial NCT04403477 ... ASCOT RECOVERY ... CONFIDENT PERUCONPLASMA Bennett-Guerrero Salman Kirenga Co-CLARITY NCT04528368 Holm K CCAP-2 Baldeon Menichetti	LIFESAVER	Libster
Early convalescent plasma.	Balcells
immunoglobulin therapy	Sakoulas
interferon
IFN beta-1a	SOLIDARITY ...
high-dose IFN beta-1a	Darazam
inhaled interferon
IFN alpha
pegylated interferon-α2b			Pandit Shashi Bhushan
recombinant super-compound interferon rSIFN-co	Li
SNG001 inhaled interferon beta	Synairgen SG016
interferon / TFF2			Fu
peginterferon			Jagannathan
PNB001			Lattmann
neutralizing antibody	ITAC
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences)	ACTIV-3 ...
bamlanivimab monotherapy	ACTIV-3/TICO LY-CoV555
casirivimab/imdevimab (Ronapreve)	RECOVERY ...		Somersan-Karakaya ...
cilgavimab and tixagevimab (Evusheld)	ACTIV-3/TICO ...
sotrovimab (Xevudy; VIR-7831)	ACTIV-3/ TICO ...
Immunosuppressants drugs
anakinra	SAVE-MORE		CORIMUNO-ANA-1
anti-interleukin-6
sarilumab	CORIMUNO-SARI-1 ...
tocilizumab	Dongsheng Wang RCT-TCZ-COVID-19 EMPACTA RECOVERY Soin AS ... Rutgers NCT04412772 ... Declercq J ... NCT04577534 ... EU-CTR2020-001375-32 ... EU-CTR2020-001748-24 ... NCT04479358 ... NCT04434717 ...	BACC Bay Tocilizumab Trial
canakinumab	Sheng ...
janus kinase (JAK) inhibitor
baricitinib	COV-BARRIER ACTT-2 ...	RECOVERY
tofacitinib	STOP-COVID ...
lenzilumab			LIVE-AIR ...
leflunomide		Wang

0 studies excluded by filtering options 0